Pasar al contenido principal

INOSITIDOS EN REDES DE SEÑALIZACION Y RUTAS METABOLICAS: HOMEOSTASIS CELULAR, CANCER Y OTRAS PATOLOGIAS

PID2020-117400GB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Spiranic compounds as novel AMPK paradoxical inhibitors: can we derive new mechanistic

  • Sanz-Gomez, Marta
  • Barmpidi, Katerina
  • Quesada-Sanchez, Sergio
  • Cumella, Jose
  • Perez, Concepcion
  • Sanz, Pascual
  • Doyaguez, Elisa G.
  • Infantes, Lourdes
  • Luque, Francisco Javier
  • Castro, Ana
  • Lagartera, Laura
  • Fernandez-Alfonso, Maria S.
  • Estarellas, Carolina
  • García-Gimeno, María Adelaida|||0000-0002-6483-3912
[EN] In this study, we synthesized and fully characterized spiranic compounds designed as conformationally restricted mimetics of A-769662 by means of crystallographic, spectroscopic, and computational methods. In vitro enzymatic assays and surface plasmon resonance experiments revealed a mixed-type inhibition mechanism. We developed a stable and equilibrated alpha 1(31 AMPK model featuring the A-loop in a closed conformation, which was used to investigate alternative binding pockets beyond the canonical AMPK sites, namely type II-like pocket. The cell-based and tissue experiments further demonstrated that these compounds act as paradoxical inhibitors, since it enhances downstream signalling by increasing phosphorylation of ACC and eNOS, ultimately activating the AMPK-eNOS-NO pathway and inducing vasodilation in rat aorta. Altogether, our findings offer new insights into AMPK modulation and highlight the potential of spiranic scaffolds as tools for probing alternative regulatory mechanisms., This research was supported by Fundacion Eugenio Rodriguez Pascual, the Spanish Ministerio de Economia y Competitividad [CEX2021-001202-M] , the Spanish Ministerio de Ciencia Innovacion y Universidades [PID2023-147942OB-I00, PID2022-142623OA-I00, PID2020-117400 GB-100] and the Generalitat de Catalunya [2021SGR00671] . Computational resources from the Barcelona Super-computing Center (BSC; BCV-2022-1-0014 and BCV-2023-2-0020) and the Consorci de Serveis Universitaris de Catalunya (CSUC; Molecular Recognition project) are acknowledged. M.S.G. thanks Universidad Complutense de Madrid for her fellowship. K.B. thanks Generalitat de Cataluna for FI fellowship [2023 FISDU 00519] .
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Substrate promiscuity of inositol 1,4,5-trisphosphate kinase driven by structurally-modified ligands and active site plasticity

  • Márquez-Moñino, María Ángeles
  • Ortega-García, Raquel
  • Whitfield, Hayley
  • Riley, Andrew M.
  • Infantes, Lourdes
  • Garrett, Shane W.
  • Shipton, Megan L.
  • Brearley, Charles A.
  • Potter, Barry V. L.
  • González, Beatriz
16 pags., 7 figs., D-myo-inositol 1,4,5-trisphosphate (InsP3) is a fundamental second messenger in cellular Ca2+ mobilization. InsP3 3-kinase, a highly specific enzyme binding InsP3 in just one mode, phosphorylates InsP3 specifically at its secondary 3-hydroxyl group to generate a tetrakisphosphate. Using a chemical biology approach with both synthetised and established ligands, combining synthesis, crystallography, computational docking, HPLC and fluorescence polarization binding assays using fluorescently-tagged InsP3, we have surveyed the limits of InsP3 3-kinase ligand specificity and uncovered surprisingly unforeseen biosynthetic capacity. Structurally-modified ligands exploit active site plasticity generating a helix-tilt. These facilitated uncovering of unexpected substrates phosphorylated at a surrogate extended primary hydroxyl at the inositol pseudo 3-position, applicable even to carbohydrate-based substrates. Crystallization experiments designed to allow reactions to proceed in situ facilitated unequivocal characterization of the atypical tetrakisphosphate products. In summary, we define features of InsP3 3-kinase plasticity and substrate tolerance that may be more widely exploitable., We are grateful to the staff of the Synchrotron Radiation Sources at Alba (Barcelona, Spain) for providing access and for technical assistance at BL13-XALOC beamline. We also acknowledge the European Synchrotron Radiation Facility ESRF (Grenoble, France) and the staff of beamlines ID23-1 and ID23-2 for assistance and support. M.A.M.-M. and this work has been supported by grants PID2020-117400GB-100 and BFU2017-89913-P from the Spanish Ministerio de Ciencia e Innovacion and Ministerio de Economia y Competitividad. B.V.L.P is a Wellcome Trust Senior Investigator (grant 101010). This research was supported by The Wellcome Trust. For the purpose of Open Access, the authors have applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Discovery of a potent melatonin-based inhibitor of quinone reductase-2 with neuroprotective and neurogenic properties

  • Herrera-Arozamena, Clara
  • Estrada-Valencia, Martín
  • García-Díez, Guillermo
  • Pérez, Concepción
  • León, Rafael
  • Infantes, Lourdes
  • Morales-García, José A.
  • Pérez-Castillo, Ana
  • Sastre, Eric del
  • López, Manuela G.
  • Rodríguez-Franco, María Isabel
5-Methoxy-3-(5-methoxyindolin-2-yl)-1H-indole (3), whose structure was unambiguously elucidated by X-ray analysis, was identified as a multi-target compound with potential application in neurodegenerative diseases. It is a low nanomolar inhibitor of QR2 (IC50 = 7.7 nM), with greater potency than melatonin and comparable efficacy to the most potent QR2 inhibitors described to date. Molecular docking studies revealed the potential binding mode of 3 to QR2, which explains its superior potency compared to melatonin. Furthermore, compound 3 inhibits hMAO-A, hMAO-B and hLOX-5 in the low micromolar range and is an excellent ROS scavenger. In phenotypic assays, compound 3 showed neuroprotective activity in a cellular model of oxidative stress damage, it was non-toxic, and was able to activate neurogenesis from neural stem-cell niches of adult mice. These excellent biological properties, together with its both good in silico and in vitro drug-like profile, highlight compound 3 as a promising drug candidate for neurodegenerative diseases., Theauthors gratefully acknowledge the following financial supports: Spanish Ministry of Science, Innovation and Universities; Spanish Research Agency; and European Regional Development Funds (grants PID2021-122650OB-I00 to M.I.R.-F.; PDC2022-133809-I00 to M.G.L., R.L., and M.I.R.-F.; PID2021-123481OB-I00 to R.L.; PID2021125986OB-I00 to M.G.L.; PID2020-117400 GB-I00 to L.I.); General Council for Research and Innovation of the Community of Madrid (grant P2022/BMD-7230 to M.G.L., R.L., and M.I.R.-F.); Spanish National Research Council (CSIC, grant PIE-202480E175 to M.I.R.-F.) Compound 3 X-ray experiments were performed at BL13-XALOC beamline at ALBA Synchrotron with the collaboration of ALBA staff. We thank the Spanish Ministry of Science, Innovation and Universities for the fellowships FPU22/03672 to G.G.-D. and FPU18/00630 to E.dS. The authors acknowledge the support of the European COST Action CA20121 (BenBedPhar) and the Fundación Teófilo Hernando, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The ALS drug riluzole binds to the C-terminal domain of SARS-CoV-2 nucleocapsid protein and has antiviral activity

  • Márquez-Moñino, María Ángeles
  • Santiveri, Clara M.
  • de León, Patricia
  • Camero, Sergio
  • Campos-Olivas, Ramón
  • Jiménez, M. Angeles
  • Sáiz, Margarita
  • González, Beatriz
  • Pérez Cañadillas, José Manuel
18 pages, 6 figures, 1 table, Nucleoproteins (N) play an essential role in virus assembly and are less prone to mutation than other viral structural proteins, making them attractive targets for drug discovery. Using an NMR fragment-based drug discovery approach, we identified the 1,3-benzothiazol-2-amine (BZT) group as a scaffold to develop potential antivirals for SARS-CoV-2 nucleocapsid (N) protein. A thorough characterization of BZT derivatives using NMR, X-ray crystallography, antiviral activity assays, and intrinsic fluorescence measurements revealed their binding in the C-terminal domain (CTD) domain of the N protein, to residues Arg 259, Trp 330, and Lys 338, coinciding with the nucleotide binding site. Our most effective compound exhibits a slightly better affinity than GTP and the ALS drug riluzole, also identified during the screening, and displays notable viral inhibition activity. A virtual screening of 218 BZT-based compounds revealed a potential extended binding site that could be exploited for the future development of new SARS-CoV-2 antivirals., Funding was provided by MCIN/AEI/10.13039/501100011033/grants: PID2020-112821GB-I00 and PID2023-146361NB-I00 (also funded by “ERDF A way of making Europe”) to J.M.P.-C. and M.A.J; and by PID2020-117400GB-100 to B.G. 19F-NMR library and experiments was accessed by payment to the service at Spectroscopy and Nuclear Magnetic Resonance Unit of the Spanish National Cancer Research Center., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The structure of human glucosidase PGGHG reveals a very specific active site accessible through a flat surface for collagen approximation

  • Casas-Flórez, David
  • Ortega-García, Raquel
  • Sanz-Benito, Paula
  • Monterroso, Begoña
  • Sanz-Aparicio, J.
  • González, Beatriz
12 pages, 7 figures, The enzyme glucosylgalactosylhydroxylysine glucosidase (PGGHG) plays a critical role in collagen metabolism by hydrolyzing the 2-O-α-d-glucopyranosyl-O-β-d-galactopyranose, a natural disaccharide found in the glycosylation of hydroxylysine residues in collagen. We report the X-ray crystallographic structure of human PGGHG, revealing the canonical four-domain fold of enzymes from the GH65 family and representing the first structure reported for a mammalian enzyme in this family. A distinctive flat surface adjacent to the catalytic site, shaped by the N-terminal β-sheet and specific conformations of catalytic loops, is unique to PGGHG among GH65 enzymes. Structural complexes with glucose and the substrate analogue kojibiose (KJB), along with site-directed mutagenesis and enzyme assays, identify residues critical for catalysis and hydroxylysine-collagen binding. Docking studies and AlphaFold3-based predictions suggest that the flat surface facilitates the contact between PGGHG and collagen peptides as well as substrate recognition, and support the enzyme's high specificity toward its glucosaccharide substrate. These findings provide structural insight into the selective recognition of glycosylated hydroxylysines and may inform future therapeutic or biotechnological applications targeting collagen metabolism., We are grateful to the Synchrotron Radiation Source at ALBA (Barcelona, Spain) for providing beamtime and assistance with the BL13- XALOC beamline. We thank the Biophysical Techniques Facility at IQF Blas Cabrera for access to the DSF equipment and excellent assistance (A. Gonzalez-Vega) with MALS experiments. We gratefully acknowledge Prof. Martín Martínez-Ripoll for his continuous assistance with updating and maintenance of the scientific software used in this work. We also thank Dr. Lourdes Infantes for her assistance with in silico protein-ligand structural prediction and virtual library preparation. This work has been supported by grant PID2020-117400GB-I00 funded by MCIN/AEI/ 10.13039/501100011033, and by grants PID2022-136951NB-I00, PID2022-136367OB-C33 and PID2023-147659NB-I00 funded by MICIU/AEI/10.13039/501100011033 and ERDF, EU. The first author has been supported by grants PID2020-117400GB-I00 and PID2023- 147659NB-I00., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Spiranic compounds as novel AMPK paradoxical inhibitors: can we derive new mechanistic insights?

  • Sanz-Gómez, Marta
  • Barmpidi, Katerina
  • Quesada-Sánchez, Sergio
  • Cumella, José
  • Pérez, Concepción
  • García-Gimeno, María Adelaida
  • Sanz, Pascual
  • Doyagüez, Elisa G.
  • Infantes, Lourdes
  • Luque, Francisco Javier
  • Castro Morera, Ana
  • Lagartera, Laura
  • Fernández-Alfonso, María S.
  • Estarellas, Carolina
In this study, we synthesized and fully characterized spiranic compounds designed as conformationally restricted mimetics of A-769662 by means of crystallographic, spectroscopic, and computational methods. In vitro enzymatic assays and surface plasmon resonance experiments revealed a mixed-type inhibition mechanism. We developed a stable and equilibrated α1β1 AMPK model featuring the A-loop in a closed conformation, which was used to investigate alternative binding pockets beyond the canonical AMPK sites, namely type II-like pocket. The cell-based and tissue experiments further demonstrated that these compounds act as paradoxical inhibitors, since it enhances downstream signalling by increasing phosphorylation of ACC and eNOS, ultimately activating the AMPK-eNOS-NO pathway and inducing vasodilation in rat aorta. Altogether, our findings offer new insights into AMPK modulation and highlight the potential of spiranic scaffolds as tools for probing alternative regulatory mechanisms., This research was supported by Fundación Eugenio Rodríguez Pascual, the Spanish Ministerio de Economía y Competitividad [CEX2021-001202-M], the Spanish Ministerio de Ciencia Innovación y Universidades [PID2023-147942OB-I00, PID2022-142623OA-I00, PID2020-117400GB-100] and the Generalitat de Catalunya [2021SGR00671]. Computational resources from the Barcelona Supercomputing Center (BSC; BCV-2022-1-0014 and BCV-2023-2-0020) and the Consorci de Serveis Universitaris de Catalunya (CSUC; Molecular Recognition project) are acknowledged. M.S.G. thanks Universidad Complutense de Madrid for her fellowship. K.B. thanks Generalitat de Cataluña for FI fellowship [2023 FISDU 00519]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Diphosphoinositol Polyphosphate Phosphohydrolase 1 family binds IP8 in catalytically-productive twist-boat and chair conformations and associates in a ligand-dependent manner

  • Casas-Flórez, David
  • Whitfield, Hayley
  • Pérez-Cañadillas, José M.
  • Monterroso, Begoña
  • Riley, Andrew M.
  • Márquez-Moñino, María Ángeles
  • Shipton, Megan L.
  • Sanz-Aparicio, J.
  • Brearley, Charles A.
  • Potter, Barry V. L.
  • González, Beatriz
[Data availability] All the atomic coordinates and the structure factors of the crystal structures are deposited in the Protein Data Bank (https://www.rcsb.org) under the submission codes 9T49 and 9T4A (DIPP1/PCP-IP8 in 1PP-SP mode); 9T48 (DIPP1-R89S/PCP-IP8 in 1PP-TB and 1PP-SP modes); 9T4B (DIPP1-R89S/PCP-IP8 in 5PP mode); 9T4C (DIPP1-H91E/PCP-IP8 in 1PP-SP and out-mode); 9T4D (DIPP1-R41A/5-IP7); 9T4G (DIPP1/IP6); 9T4H (DIPP1-R41A/IP6); 9T4I (DIPP1-R89S/IP6); 9T4J (DIPP1-H91E/IP6); 9T4K (DIPP1-H91M/IP6); 9T4L (DIPP1-E108N/IP6); 9T4M (DIPP1-N112S/IP6); 9T4E (DIPP1); 9T4F (DIPP1-E108N)., Diphosphoinositol Polyphosphate Phosphohydrolase 1 (DIPP1) is a Nudix hydrolase involved in inositol pyrophosphate (PP-InsP) metabolism, critical for cellular signaling, energy homeostasis, and stress responses. We report crystallographic and computational studies that reveal 1,5-bis-diphosphoinositol tetrakisphosphate (IP8) binds to DIPP1 in two catalytically-productive inositol ring conformations. IP8 hydrolysis at the 1-position requires a twist-boat conformation, whereas at the 5-position a canonical chair conformation is adopted. Additionally, structural and biophysical characterization shows that the DIPP1 family undergoes ligand-sensitive changes in the association state that might be further modulated by salt concentration and/or phosphate ions. Taken together, these results advance our understanding of DIPP1 in the dynamic regulation of inositol pyrophosphate signaling networks. They provide a detailed view of DIPP1 substrate recognition and suggest oligomerization as a novel regulatory mechanism, with broader implications for phosphate sensing and functional protein-protein interactions., We are grateful to the European Synchrotron Radiation Facility for provision of synchrotron radiation facilities and we would like to thank the staff of the ESRF and EMBL Grenoble for assistance and support in using beamlines ID23-1, ID23-2, ID30-B and ID30-A3 (BAG proposal numbers MX2364 and MX2465). We also thank the Synchrotron Radiation Source at ALBA (Barcelona, Spain) for providing beamtime and assistance with the BL13-XALOC beamline. We gratefully acknowledge Prof. Martín Martínez-Ripoll for his valuable assistance with updating and maintenance of the scientific software used in this work. We also thank Dr. Lourdes Infantes for her assistance with in silico protein-ligand structural prediction. We thank Paula Sanz-Benito for valuable technical assistance. We thank Carlota Menéndez Linacero for her help in setting up the 5-IP7 biosynthesis. We thank the Biophysical Techniques Facility at IQF Blas Cabrera for access to the DSF equipment and for excellent assistance (A. González-Vega) with DLS experiments, and the Molecular Interactions Facility at CIB Margarita Salas (J.R. Luque-Ortega) for assistance in AUC experiments. The authors acknowledge the computational resources provided by the Galician Supercomputing Center (CESGA). The FinisTerrae III supercomputer and its permanent data storage system were funded by the NextGeneration EU 2021 Recovery, Transformation and Resilience Plan (ICT2021-006904), the Pluriregional Operational Programme of Spain 2014–2020 of the European Regional Development Fund (ERDF) (ICTS-2019-02-CESGA-3), and the State Programme for the Promotion of Scientific and Technical Research of Excellence, within the State Plan for Scientific and Technical Research and Innovation 2013–2016, State Subprogramme for Scientific and Technical Infrastructures and Equipment of ERDF (CESG15-DE-3114). D.J.C-F. and this work has been supported by grants PID2020-117400GB-I00 and PID2023-147659NB-I00 funded by MCIN/AEI/10.13039/501100011033 and ERDF, a way of making Europe. The work has also been supported by grants PID2023-146361NB-I00 (to J.M.P.-C.) and PID2022-136951NB-I00 (to B.M.), funded respectively by MCIN/AEI/10.13039/501100011033 and MICIU/AEI/10.13039/501100011033, and by ERDF, EU. B.V.L.P. is a Wellcome Trust Senior Investigator (Grant 101010). H.W. was supported by NERC (UKRI) NE/W000350/1. This work was funded in part by the Wellcome Trust. For the purpose of Open Access, the authors have applied a CC BY public copyright license to any author-accepted manuscript version arising from this submission., Peer reviewed